A selection of published studies.

agaDA* - a result of 20 years of research and 26 published studies.

studies

Effect and safety has been shown on more than 2000 people
For us at MedicineGarden, studies are a matter of course. Because it is about your health. Through repeated studies, both clinical i.e. on humans and in the laboratory, efficacy, safety, absorption and mechanism can be ensured. And this is important because the efficacy of a plant extract varies depending on where it has been grown, when it has been harvested and above all - the extraction method used. Studies are therefore the only objective way to show that a product delivers what it promises. That's why you can trust agaDA.

Some of the studies we refer to are for indications outside the scope of the health claims registered with EFSA. However, since the results are a consequence of the fact that the adaptogens in agaDA contribute to normal functioning of the immune system, airways and recovery - we have chosen to make the studies available.

* agaDA contains: Andrographis (SHA-10®) which contributes to the normal functioning of the immune system and respiratory system and the physical well-being of the body. Russian root (SHE-3®) contributes to mental and physical stamina in case of exhaustion and fatigue during recovery and convalescence. As an adaptogen, Russian root also contributes to the body's overall resilience.

Absence from work and school halved. The difference was measurable on day two. (2021)

Early intervention with agaDA®: A randomized, quadruple-blind study. (179 patients)

Efficiency increases by over 50% when Andrographis (SHA-10) and Russian root (SHE-3) are combined (2021).

Synergy of Herba Andrographis and Radix Eleutherococcus Preparations.

agaDA supports recovery and convalescence (2021)

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of agaDA Capsules (86 patients).

Intake of 2 capsules of agaDA during three winter months halved absenteeism. (1997)

Prevention of common colds with Andrographis paniculata dried extract: A Pilot double blind trial (107 youngsters, 18 years).

Study of 133 young people shows recovery and well-being (2004)

Comparative controlled study of agaDA and an Echinacea preparation as adjuvant in children.

Rapid effect. Andrographis SHA-10 is absorbed to 100% already after 90 minutes. (2000)

Pharmacokinetic and oral bioavailability of andrographolide from agaDA in rats and human.

A normal well-functioning immune system important for recovery, physical fitness and fatigue (2003).

A randomized, controlled study of agaDA (606 patients).

Rapid recovery, well-being and stamina. A result of a normally functioning immune system (2002).

A double blind, placebo-controlled study of agaDA (185 patients).

Clear difference in recovery between agaDA and placebo. (2000)

Double-blind, placebo-controlled pilot and Phase III study of activity of agaDA (225 patients).

Greater well-being and less fatigue on day two. (1999)

Use of visual analogue scale measurements (VAS) to assess the effectiveness of agaDA. A randomized double blind-placebo study. (158 patients)